The latest myeloma treatment advances from ASCO 2023
The 2023 American Society of Clinical Oncology (ASCO) annual meeting was held from June 2 to 6 in Chicago! Clinicians and researchers gathered to present and discuss several updates in multiple myeloma relating to: Chimeric antigen receptor (CAR) T-cell therapies, Bispecific antibodies (also known as T-cell engagers) in combination or as monotherapy, Treatment for newly diagnosed disease, and Maintenance therapy. Let us break down the key findings for you…
Link: https://themmrf.org/2023/06/08/the-latest-myeloma-treatment-advances-from-asco-2023/
In 2018, 18 trekkers completed an awe-inspiring hike of the Himalayan highlands to the doorstep of the world’s tallest mountain, Mount Everest, to raise awareness and funding for multiple myeloma, a type of blood cancer. Three of the climbers discuss a bond that hasn’t broken.
Read More
